UCB - Celltech Merger - A Strategic Snapshot

UCB - Celltech Merger - A Strategic Snapshot

 

RELEASE DATE
03-Jun-2004
REGION
Global
Research Code: A988-01-00-00-00
SKU: HC00991-GL-MR_04900

$1,800.00

Special Price $1,350.00 save 25 %

In stock
SKU
HC00991-GL-MR_04900

$1,800.00

$1,350.00 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The white paper, The UCB-Celltech Merger – A Strategic Snapshot, includes the details of the merger, stock analysis, and product pipeline analysis of Celltech. The white paper includes analysis of Celltech's lead product CDP-870 and its market potential, rheumatoid arthritis and Crohn’s disease market overview, competitive analysis of biologics for rheumatoid arthritis, and impact of the merger on pharmaceutical and biotechnology industry

Table of Contents

UCB-Celltech Merger

  • UCB-Celltech Merger - A Strategic Snapshot
Related Research
The white paper, The UCB-Celltech Merger  A Strategic Snapshot, includes the details of the merger, stock analysis, and product pipeline analysis of Celltech. The white paper includes analysis of Celltech's lead product CDP-870 and its market potential, rheumatoid arthritis and Crohns disease market overview, competitive analysis of biologics for rheumatoid arthritis, and impact of the merger on pharmaceutical and biotechnology industry
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number A988-01-00-00-00
Is Prebook No